Afugan

Afugan is a pharmaceutical drug used in the treatment of pain management. It is a potent opioid analgesic, often used in clinical settings for its effectiveness in relieving severe pain.

Pharmacology

Afugan's primary active ingredient is fentanyl, a synthetic opioid that is 50 to 100 times more potent than morphine. It works by binding to the body's opioid receptors, which are found in areas of the brain that control pain and emotions. When opioids bind to these receptors, they can drive up dopamine levels in the brain's reward areas, producing a state of euphoria and relaxation.

Medical Uses

Afugan is used for managing acute and chronic pain, particularly in individuals for whom other treatments have proven ineffective. It is also used in surgical procedures as a part of the anesthesia process to help prevent pain following surgery.

Side Effects

Like all opioids, Afugan has potential side effects, including drowsiness, nausea, constipation, and, at higher doses, respiratory depression. It also carries a risk of opioid addiction, particularly with long-term use.

Regulation

Due to its potency and potential for abuse, Afugan is classified as a Schedule II controlled substance in the United States under the Controlled Substances Act. This means it has a high potential for abuse, with use potentially leading to severe psychological or physical dependence.

See Also

• Opioid epidemic
• Pain management
• Fentanyl

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian